Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia

INTRODUCTION: Current therapy options for chronic myeloid leukemia (CML) include conventional chemotherapy, allogeneic stem cell transplant, interferon-alfa, and imatinib mesylate, which has recently achieved gold standard status. Although the majority of patients initially respond well to treatment...

Descripción completa

Detalles Bibliográficos
Autor principal: Haslam, Sonya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Emerging Therapy Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321652/
https://www.ncbi.nlm.nih.gov/pubmed/22496672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321652/
https://www.ncbi.nlm.nih.gov/pubmed/22496672

Ejemplares similares